Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer

J Thorac Cardiovasc Surg. 2004 Sep;128(3):489-90. doi: 10.1016/j.jtcvs.2004.04.028.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Non-Small-Cell Lung / therapy*
  • Combined Modality Therapy
  • Humans
  • Lung Neoplasms / pathology
  • Lung Neoplasms / therapy*
  • Neoplasm Staging